Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 Inhibition
Clinical trial NCT06605586 · RECRUITING
Trial details
- NCT number
- NCT06605586
- Sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-20
- Primary completion
- 2027-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.